Recently, the international investment bank Torreya Corporation released the 2021 "Report on the World's Top Thousand Pharmaceutical Companies". The report ranks the world's top 1,000 pharmaceutical companies based on valuation. There are 249 pharmaceutical companies in China on the list. Among the world's top 100 pharmaceutical companies, China is shortlisted for 20.
Compared with the 208 top 1,000 Chinese companies in 2020, the number of Chinese medicine companies in 2021 will increase by 19.71% year-on-year. Among the shortlisted Chinese companies, the top five are Hengrui Pharmaceutical , CSPC , Qilu Pharmaceutical , Yangzijiang Pharmaceutical, Pien Tzehuang . Among them, Hengrui Medicine has ranked first among China's listed pharmaceutical companies for two consecutive years.
In addition, there are 20 Chinese pharmaceutical companies that are shortlisted in the top 100. Respectively, Hengrui Pharmaceutical ranked 24th, CSPC ranked 25th, Qilu Pharmaceutical ranked 26th, Yangtze River Pharmaceutical ranked 28th, Pien Tze Huang ranked 33, Zhifei Biotechnology ranked 36th, BeiGene 38th, Fosun Pharma 53rd, Amec 54th, Changchun Biotech 57th, Kelun Pharmaceuticals 59th, Jimin Trust 60th, Sino Biopharmaceutical is 67th, Yunnan Baiyao is 71, Watson Bio is 74, Cinda Bio is 77, Kangtai Bio is 78, Hausen Pharmaceutical is 82, Shanghai Pharmaceuticals 88th place, Huadong Medicine 92nd place.
The report shows that China's pharmaceutical industry has become the second largest player in the global pharmaceutical industry. The top five countries in the global pharmaceutical industry are the United States, China, Switzerland, the United Kingdom and Germany.From 2003 to 2021, large pharmaceutical companies maintained their share of value. Among them, the Chinese pharmaceutical industry grew rapidly, from 1% in 2003, 11% in 2020, to 13% in 2021, with a total value of approximately 840.261 billion.
Previously, the "Future of the Global Pharmaceutical Industry" report released by Torreya showed that the vigorous development of the Chinese market will continue to play a pivotal role in the next stage of the development of the entire pharmaceutical industry. In the next 50 years, the Chinese pharmaceutical industry market The scale will increase by 4 times, while the growth of the US and European markets will be less than 2 times.
Source: Health Times Client
Arrangement: Dai Wei Xia Bingbing
.
